| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cisplatin Monotherapy as a Treatment Option for Patients with HER-2 Negative Breast Cancer Experiencing Hepatic Visceral Crisis or Impending Visceral Crisis
|
Püsküllüoğlu, Mirosława
|
|
|
12 |
3 |
p. 419-435
|
artikel
|
| 2 |
Cost-effectiveness of Pembrolizumab in Combination with Chemotherapy as Neoadjuvant Treatment and Continued as a Single Agent Adjuvant Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer in Hong Kong
|
Kwong, Ava
|
|
|
12 |
3 |
p. 525-547
|
artikel
|
| 3 |
Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know
|
Zhou, Yang
|
|
|
12 |
3 |
p. 375-394
|
artikel
|
| 4 |
Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient Survey
|
Hamilton, Betty K.
|
|
|
12 |
3 |
p. 451-464
|
artikel
|
| 5 |
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy
|
Gentzler, Ryan D.
|
|
|
12 |
3 |
p. 509-524
|
artikel
|
| 6 |
Early Identification and Management of Patients with Rash on Apalutamide
|
Birtle, Alison J.
|
|
|
12 |
3 |
p. 609-620
|
artikel
|
| 7 |
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy
|
Scafuri, Luca
|
|
|
12 |
3 |
p. 363-373
|
artikel
|
| 8 |
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population
|
Delea, Thomas E.
|
|
|
12 |
3 |
p. 565-583
|
artikel
|
| 9 |
Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease
|
Franklin, Matthew
|
|
|
12 |
3 |
p. 491-508
|
artikel
|
| 10 |
Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma
|
Delamain, Marcia Torresan
|
|
|
12 |
3 |
p. 585-598
|
artikel
|
| 11 |
Palbociclib in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer: A Systematic Scoping Review of Real-World Evidence from Countries Outside of Western Regions that Are Underrepresented in Clinical Trials
|
Rauthan, Amit
|
|
|
12 |
3 |
p. 395-418
|
artikel
|
| 12 |
Patient Characteristics Associated with Time to Next Treatment in Patients with Ovarian Cancer Treated with Niraparib: The PRED1CT Real-World Study
|
Chase, Dana M.
|
|
|
12 |
3 |
p. 599-607
|
artikel
|
| 13 |
Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind Study
|
Schwabe, Christian
|
|
|
12 |
3 |
p. 477-490
|
artikel
|
| 14 |
Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study
|
Rimel, Bobbie
|
|
|
12 |
3 |
p. 465-475
|
artikel
|
| 15 |
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population
|
Gagliato, Debora
|
|
|
12 |
3 |
p. 437-449
|
artikel
|
| 16 |
Treatment Patterns and Resource Use After Osimertinib Discontinuation in Patients with EGFR + Metastatic NSCLC
|
Marrett, Elizabeth
|
|
|
12 |
3 |
p. 549-563
|
artikel
|
Tijdschrift beschrijving